Nice to meet you

My work spans from first-in-human testing of novel therapeutics to their application in patients with complex diseases. As an internationally recognized leader in polypharmacy, drug safety, and medicines optimization, I am dedicated to delivering better and safer medications for individuals living with multimorbidity.

My clinical expertise extends to leading outpatient clinics, inpatient reviews, and multidisciplinary team meetings for adults with complex multimorbidity and polypharmacy.

Passionate about advancing healthcare through research and collaboration, I am committed to optimizing medication use and improving patient outcomes on a national and international scale.

Education & Training Offerings

Polypharmacy & Multimorbidity Management

Understanding drug interactions and disease progression in complex patients.

Medicines Optimization & Deprescribing

Identifying when medication harms outweigh benefits.

AI & Machine Learning in Clinical Decision-Making

Exploring how AI-driven insights enhance prescribing and risk prediction.

Experimental Therapeutics & Drug Development

Understanding early-phase clinical trials and novel therapies.

Research & Innovations

AI-driven prescribing optimization

Identifying disease and prescribing trajectories in people with complex care needs. Visit

Health record analytics

Using machine learning to predict risks and improve patient safety.

Explore my AI-driven research

DynAIRx: Artificial Intelligence (AI)

SERENDIP AI

Clinical decision support tools

Developing tools for optimizing HIV prescribing and multimorbidity care.

Clinical & Leadership Roles

Deputy Director, NIHR Clinical Research Facility

Supporting early-phase clinical trials and precision medicine research.

Professor of Clinical Pharmacology & Therapeutics

Managing complex multimorbidity cases, inpatient reviews, and multidisciplinary team meetings.

Senior Investigator, AGILE Trial

Co-leading UK’s only government-funded early-phase COVID-19 therapeutic trial. Visit

Co-Director -TherEx

Innovating therapies for complex diseases with a particular focus on infection therapeutics

Chief Investigator

High-Dose Nitazoxanide Repurposing for COVID-19 – Ensuring low-cost global solutions through Unitaid-funded research.

Co-Chair

INational Polypharmacy Services Consortium (PPSC) – Developing an integrated, multidisciplinary approach to polypharmacy management.

Co-Director of NIHR

Cheshire & Mersey Commercial Research Delivery Centre

DynAIRx

DynAIRx (Artificial Intelligence for dynamic prescribing optimisation and care integration in multimorbidity) aims to develop new, easy to use, artificial intelligence (AI) tools that support General Practitioners (GPs) and pharmacists to find patients living with multimorbidity (two or more long-term health conditions) who might be offered a better combination of medicines.